Outsourced Pharma White Papers
-
The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics
2/4/2026
Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.
-
Navigating Complex OSD Challenges With Predictive Insights
7/20/2026
Learn how predictive modeling, advanced material characterization, and data-driven process insights support manufacturing readiness and confident launch decisions.
-
Choosing The Best Amorphous Dispersion Path Before It Costs You
6/22/2026
Parallel screening across multiple solid dispersion platforms early optimizes drug solubility and stability, building a strong technical foundation that prevents costly development delays.
-
Implementing Medium And High-Volume Drug Handling And Packaging Programs
4/23/2026
Simplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.
-
Empowering Antibody Discovery With ProSpeed™
11/25/2025
Integrating linear expression technology into single B cell workflows accelerates antibody discovery, enabling early functional screening, improved sensitivity, and cost-effective identification of diverse therapeutic candidates.
-
Quality As A Strategic Differentiator In Drug Development
9/21/2026
When quality functions as an operational discipline rather than a downstream control, it stabilizes complex drug development programs rather than slowing them down. This paper examines what that requires in practice.
-
If You Can't Win The Game, Change It
12/11/2024
Explore how eData sharing is used in the biopharma market, enabling standardized, collaborative supply chains that reduce risks and enhance visibility while improving capacity planning.
-
AI Enabled Pharmaceutical Cocrystal Screening
9/3/2026
Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.
-
Systematic Strategy To Reduce The Cost Of Goods Sold
3/26/2026
Learn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.
-
Modern Modeling Tools For Small Molecule Solid Dose Manufacturing
3/10/2025
Data-driven modeling techniques can enhance scale-up processes, streamline production, and help companies navigate the complexities of modern drug development with greater precision and reliability.